Scientific Industries Announces Third Quarter 2025 Results And Launch of VIVID's New AI-Powered Feature

Core Insights - Scientific Industries, Inc. reported a 52.2% increase in net revenues for Q3 2025, reaching $1.404 million compared to $1.334 million in Q3 2024, driven by strong performance in the Torbal Division [6][8] - The company launched an AI-powered feature for its VIVID WORKSTATION, enhancing pharmacy automation and compliance [4][6] - The divestiture of the Genie brand portfolio has allowed the company to focus on high-growth segments, particularly in pill counting [4] Business Highlights - The Torbal Division experienced a 15% year-over-year sales increase, contributing significantly to overall revenue growth [6][8] - VIVID products saw a 27% year-over-year sales increase, indicating strong market demand [6] - The company introduced a new prescription label documentation and verification feature for the VIVID WORKSTATION, utilizing AI technology [6] Financial Overview - For the nine months ended September 30, 2025, net revenues decreased by 2.5% to $3.427 million from $3.515 million in the prior year, primarily due to decreased revenues in Bioprocessing Systems Operations [8] - Gross profit for Q3 2025 was $0.639 million, with a gross margin of 45.5%, down from 51.0% in Q3 2024 [6][9] - The company reported a net income of $3.994 million for Q3 2025, a significant turnaround from a net loss of $1.180 million in Q3 2024 [12][23] Management Commentary - The CEO emphasized the importance of continuous innovation across hardware, firmware, and software to maintain leadership in automated pill counting solutions [4] - The Chairman highlighted the introduction of a new dissolved oxygen sensor for baffled flasks, which has led to new customer wins and improved experimental reproducibility [5] - Despite challenges such as tariffs and reduced government funding affecting customer budgets, the company remains optimistic about future growth [5]